CLINICAL ROLE -
Biosimilars: Are They Delivering the Cost Savings Promised?
Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
Read More